secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2021-07-29T23:59:59+00:00
Accession:  0001104659-21-097603
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SUPN CFO James P. Kelly resigns; Timothy C. Dec appointed as new CFO
--------------------------------------------------------------------

- James P. Kelly resigns as EVP & CFO effective August 13, 2021 to join another company.
- Timothy C. Dec appointed SVP & CFO effective August 23, 2021; over 35 years experience, most recently CFO of OpGen.
- Dec receives $375,000 annual base salary, 40% target bonus prorated first year, and 85,000 options vesting over 4 years.
- Dec enters Executive Retention Agreement with severance payments and accelerated vesting upon change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000110465921097603/0001104659-21-097603-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000110465921097603/tm2123591d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-097603

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer